ストックスクリーナーアプリを入手
110.22
0.86%
-0.546
前日終値:
$110.77
開ける：
$109.75
24時間の取引高:
546.27K
Relative Volume:
0.57
時価総額：
$5.10B
収益：
-
当期純損益:
$-63.78M
株価収益率:
-41.13
EPS:
-2.68
ネットキャッシュフロー:
$-53.91M
1週間 パフォーマンス:
+2.67%
1か月 パフォーマンス:
+7.30%
6か月 パフォーマンス:
+681.64%
1年 パフォーマンス:
+841.85%
1日の値動き範囲:
$103.00
$112.20
1週間の範囲:
$103.00
$112.69
52週間の値動き範囲:
$7.575
$116.44
Celcuity Inc Stock (CELC) Company Profile
CELC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
110.20 | 5.13B | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.40 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.13 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
815.50 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.91 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.33 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-12 | 開始されました | Wells Fargo | Overweight |
| 2025-11-18 | 開始されました | Wolfe Research | Outperform |
| 2025-11-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-09-22 | 開始されました | Guggenheim | Buy |
| 2025-07-01 | 再開されました | Stifel | Buy |
| 2024-07-22 | 開始されました | Leerink Partners | Outperform |
| 2024-02-22 | 開始されました | Stifel | Buy |
| 2023-12-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-09-07 | 開始されました | Jefferies | Buy |
| 2021-07-29 | 開始されました | Cowen | Outperform |
| 2021-07-27 | 開始されました | Needham | Buy |
| 2021-01-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-12-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-11 | 再開されました | Craig Hallum | Buy |
| 2018-11-20 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Celcuity Inc (CELC) 最新ニュース
Celcuity Inc. (CELC) Stock Analysis: Exploring the Biotechnology Innovator’s Growth Potential - DirectorsTalk Interviews
Reassessing Celcuity (CELC) Valuation After A 51.85% Three Month Share Price Gain - Yahoo Finance
(CELC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
FDA accepts Celcuity’s NDA for gedatolisib with priority review By Investing.com - Investing.com Canada
Celcuity wins FDA review for breast cancer drug (CELC:NASDAQ) - Seeking Alpha
FDA Accepts Celcuity's NDA For Gedatolisib In HR+, HER2- Advanced Breast Cancer - Nasdaq
FDA accepts Celcuity’s NDA for gedatolisib with priority review - Investing.com
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer - The Manila Times
Celcuity Announces FDA Acceptance of New Drug Application - GlobeNewswire
Short Interest in Celcuity, Inc. (NASDAQ:CELC) Expands By 20.9% - MarketBeat
Dow Update: Can POAI lead its sector in growth2025 Valuation Update & Long-Term Safe Investment Ideas - baoquankhu1.vn
Merger Talk: Is Madison Square Garden Sports Corp stock forming a cup and handleJuly 2025 Rallies & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Chart Watch: Can Celcuity Inc disrupt its industryJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Nisa Investment Advisors LLC Buys 14,930 Shares of Celcuity, Inc. $CELC - MarketBeat
CELC Stock Price, Forecast & Analysis | CELCUITY INC (NASDAQ:CELC) - Chartmill
Celcuity (NASDAQ:CELC) Shares Down 6.2%Should You Sell? - MarketBeat
This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why - MSN
Celcuity stock reaches all-time high at 112.78 USD By Investing.com - Investing.com Nigeria
Celcuity (NASDAQ:CELC) Reaches New 1-Year HighStill a Buy? - MarketBeat
Celcuity stock reaches all-time high at 112.78 USD - Investing.com
Market Wrap: Can Celcuity Inc ride the EV waveJuly 2025 Closing Moves & Short-Term High Return Ideas - baoquankhu1.vn
Macro Review: Can Celcuity Inc. stock beat analyst upgrades2025 Volume Leaders & Growth-Oriented Investment Plans - Bộ Nội Vụ
The Bull Case For Celcuity (CELC) Could Change Following Shelf Registration And FDA Review ProgressLearn Why - simplywall.st
Celcuity (NASDAQ:CELC) Shares Gap DownHere's What Happened - MarketBeat
Wells Fargo initiates coverage on Celcuity Inc. (CELC) - MSN
Wells Fargo Initiates Coverage On Celcuity Inc. (CELC) - Finviz
Celcuity (CELC) surges 662% in 2025 on breast cancer treatment trial results - MSN
How (CELC) Movements Inform Risk Allocation Models - Stock Traders Daily
Risks Report: Is American National Group Inc stock attractive for long term wealth buildingMarket Sentiment Report & Trade Opportunity Analysis Reports - moha.gov.vn
Celcuity files for mixed shelf size not disclosedSEC filing - marketscreener.com
Celcuity Inc. (CELC) Investor Outlook: Analyzing the Biotechnology Stock with a $4.84 Billion Market Cap - DirectorsTalk Interviews
Why Celcuity Inc. stock is a value investor pickJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - Улправда
Can Celcuity Inc. stock beat analyst upgradesJuly 2025 Review & Precise Swing Trade Entry Alerts - ulpravda.ru
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire
Is Celcuity Inc. stock attractive after correction2025 Trading Volume Trends & AI Powered Buy and Sell Recommendations - ulpravda.ru
Gains Recap: Can Celcuity Inc stock sustain free cash flow growthMarket Sentiment Review & AI Enhanced Market Trend Forecasts - moha.gov.vn
What valuation multiples suggest for Celcuity Inc. stockMean Reversion Trades & Exceptional Profit Growth - ulpravda.ru
Celcuity initiated with an Outperform at Wolfe Research - MSN
Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase? - The Globe and Mail
2025’s best-performing Minnesota public company stock is a biopharmaceutical firm with no revenue - MSN
Analysts Expect Breakeven For Celcuity Inc. (NASDAQ:CELC) Before Long - 富途牛牛
What analysts say about Celcuity Inc stockWeekly Market Snapshot & You’ll Thank Yourself in 6 Months - earlytimes.in
Celcuity (CELC) Surges 662% in 2025 on Breast Cancer Treatment Trial Results - Insider Monkey
Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey
Celcuity, Inc. (NASDAQ:CELC) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Trading Systems Reacting to (CELC) Volatility - Stock Traders Daily
Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond (NASDAQ:CELC) - Seeking Alpha
Celcuity (CELC)’s Clinical Success and M&A Potential Underpin Wolfe Research’s Bullish View - MSN
Celcuity Inc. Earnings Call: Strong Progress Amid Challenges - MSN
Net current asset value per share of Celcuity Inc. – GETTEX:7VR - TradingView — Track All Markets
ETFs Investing in Celcuity Inc. Stocks - TradingView — Track All Markets
Celcuity Inc (CELC) 財務データ
収益
当期純利益
現金流量
EPS
3.31%
2.06%
大文字化:
|
ボリューム (24 時間):